Status:
COMPLETED
Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
Lead Sponsor:
ALK-Abelló A/S
Conditions:
Allergy
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
We plan to determine changes in the immune system during the allergic response to grass pollen allergens. We have chosen a particular element of the immune response, the immunoglobulin G4 (IgG4) as an...
Eligibility Criteria
Inclusion
- A history of grass pollen allergy
- Positive skin prick test to grass
- Positive specific IgE to grass
Exclusion
- Treatment with anti-IgE
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00413556
Start Date
January 1 2007
End Date
December 1 2007
Last Update
March 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico San Carlos
Madrid, Madrid, Spain, 28040